Cancer

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

1 year ago

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

1 year ago

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

PHILADELPHIA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell…

1 year ago

Rezolut Announces Strategic Partnership with Women’s Health of Arizona

Leading Provider of White Label Mammography Expands Footprint in ArizonaPHOENIX, AZ / ACCESSWIRE / December 5, 2023 / Rezolut, LLC,…

1 year ago

Veteran Brings Lawsuit Against U.S. Government and Cerner After Defective Veterans Affairs Electronic Health Record (EHR) System Irreparably Delays Cancer Diagnosis, According to Luvera Law Firm

Charlie Bourg’s prostate cancer could have been caught early and potentially treated – but after a 17-month delay in diagnosis,…

1 year ago

MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI+

Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM…

1 year ago

MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI+

Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and PhysiciansCLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM…

1 year ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today…

1 year ago